Péré, Hélène <br/><br/>
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.  [electronic resource] 

 -  AIDS research and human retroviruses  Apr 2012 
 - 315-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1931-8405 
<br/><br/><label>Standard No.: </label>10.1089/aid.2011.0127  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Atazanavir Sulfate<br/>CD4 Lymphocyte Count<br/>Central African Republic--epidemiology<br/>DNA Fingerprinting<br/>Drug Resistance, Viral--drug effects<br/>Female<br/>Genetic Variation<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>HIV-1--drug effects<br/>Health Services Accessibility--statistics & numerical data<br/>Humans<br/>Lopinavir--therapeutic use<br/>Male<br/>Oligopeptides--therapeutic use<br/>Organophosphonates--therapeutic use<br/>Prospective Studies<br/>Pyridines--therapeutic use<br/>RNA, Viral--drug effects<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Tenofovir<br/>Viral Load--drug effects<br/>Young Adult<br/>Zidovudine--therapeutic use<br/>Assessment of Medication Adherence